Mabwell (Shanghai) Bioscience Co (SHSE:688062) LT-Debt-to-Total-Asset : 0.27 (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Mabwell (Shanghai) Bioscience Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Mabwell (Shanghai) Bioscience Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.27.

Mabwell (Shanghai) Bioscience Co's long-term debt to total assets ratio increased from Dec. 2023 (0.24) to Dec. 2024 (0.27). It may suggest that Mabwell (Shanghai) Bioscience Co is progressively becoming more dependent on debt to grow their business.

Mabwell (Shanghai) Bioscience Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Mabwell (Shanghai) Bioscience Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabwell (Shanghai) Bioscience Co LT-Debt-to-Total-Asset Chart

Mabwell (Shanghai) Bioscience Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.06

0.19

0.14

0.24

0.27

Mabwell (Shanghai) Bioscience Co Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.24	0.25	0.27	0.25	0.27

Mabwell (Shanghai) Bioscience Co LT-Debt-to-Total-Asset Calculation

Mabwell (Shanghai) Bioscience Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	1149.412	/	4275.509
	=	0.27

Mabwell (Shanghai) Bioscience Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	1149.412	/	4275.509
	=	0.27

Mabwell (Shanghai) Bioscience Co (SHSE:688062) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Mabwell (Shanghai) Bioscience Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Mabwell (Shanghai) Bioscience Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Mabwell (Shanghai) Bioscience Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabwell (Shanghai) Bioscience Co Ltd (SHSE:688062) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 230, Cailun Road, Room 105, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201210

Website

https://www.mabwell.com

Mabwell (Shanghai) Bioscience Co Ltd is engaged in the research and development, production and sales of therapeutic biological products.

Mabwell (Shanghai) Bioscience Co Headlines

No Headlines